Koers Syneos Health, Inc.
Aandelen
SYNH
US87166B1026
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
Michael Bonello
DFI | Director of Finance/CFO | 55 | 01-07-23 |
Michael Brooks
COO | Chief Operating Officer | 50 | 14-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Momtazee
BRD | Director/Board Member | 52 | 28-09-23 |
Colin Shannon
CEO | Chief Executive Officer | 65 | 28-09-23 |
James Dimitri
BRD | Director/Board Member | - | 28-09-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.82% | 8 M€ | -.--% | ||
0.77% | 2 M€ | +6,54% | ||
0.50% | 0 M€ | 0,00% | - | |
0.36% | 0 M€ | 0,00% | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,82% | 41,35 mld. | |
+44,25% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |